Urteste S.A. (WSE:URT)

Poland flag Poland · Delayed Price · Currency is PLN
87.40
-2.20 (-2.46%)
Feb 21, 2025, 2:06 PM CET
-16.76%
Market Cap 126.59M
Revenue (ttm) n/a
Net Income (ttm) -3.37M
Shares Out 1.41M
EPS (ttm) -2.39
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1
Average Volume 94
Open 89.00
Previous Close 89.60
Day's Range 87.40 - 87.40
52-Week Range 73.00 - 112.50
Beta 0.17
RSI 48.57
Earnings Date Jan 27, 2025

About Urteste

Urteste S.A. engages in the research and development of diagnostic tests for cancers. It offers diagnostic tests for pancreas, prostate, kidney, colon, liver, biliary tract, stomach, lung, oesophagus, ovary, endometrium, blood, breast, and nervous system cancer. The company was incorporated in 2021 and is based in Gdansk, Poland. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2021
Employees 20
Stock Exchange Warsaw Stock Exchange
Ticker Symbol URT
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.